ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,321.94
1.15%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Biostar Pharmaceuticals Inc (CE) (BSPM)

  7. Biostar Pharmaceuticals Inc (CE) (BSPM) News

Biostar Pharmaceuticals (CE) (BSPM)

Biostar Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BSPM
DateTimeSourceHeadlineSymbolCompany
08/01/201915:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/08/201814:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/08/201813:51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
25/07/201821:34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
06/07/201821:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/07/201822:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
30/05/201821:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
16/05/201821:12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/04/201821:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/04/201821:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/02/201821:53Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/02/201821:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/02/201821:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/12/201721:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/12/201721:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
04/12/201721:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/11/201721:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201722:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201721:34Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/08/201721:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/08/201714:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
12/06/201722:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/05/201721:24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/05/201722:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201721:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/04/201721:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
03/04/201721:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/02/201721:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
09/02/201721:33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/01/201711:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:BSPM

Your Recent History

LSE
NG.
National Grid
LSE
POS
Plexus
LSE
SRSP
Sirius Petroleum
LSE
BIRD
Blackbird
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
CUSN
Cornish Metals
LSE
SCLP
Scancell
LSE
AVCT
Avacta
LSE
GOLD
LSE
ZED
Zenova
LSE
LLOY
Lloyds Banking
LSE
CHLL
Chill Brands
LSE
BOO
Boohoo
LSE
SAR
Sareum
LSE
GGP
Greatland Gold
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved